WORD OF HOPE™ Ovarian Cancer Podcast Now Available Through New Website, iTunes, YouTube, and Other Online Sources.
A new ovarian cancer educational podcast series, entitled “WORD of HOPE™,” was launched during Women’s Health Awareness Week through a collaborative initiative of Libby’s H*O*P*E*™ (LH) and Women’s Oncology Research & Dialogue (WORD).
The WORD of HOPE™ Ovarian Cancer podcast series will address important topics related to ovarian cancer, including prevention, early detection, diagnosis, groundbreaking treatments, scientific and clinical research information, and related women’s health information for ovarian cancer patients, caregivers and advocates. The WORD of HOPE™ podcast series can be found online at http://www.wordofhopepodcast.com, and is available to viewers and listeners for subscription at the WORD Of HOPE™ podcast website, iTunes, and YouTube.
“From the beginning, WORD has been committed to taking the most important scientific information and providing patients, caregivers and advocates the easily accessible resources to educate and inspire during their journey of care. As a physician, nearly every day we are looking for resources to give newly diagnosed patients and their supporters to help them better understand their diagnosis and treatment options. We are proud to partner with Libby’s H*O*P*E*™ and its founder Paul Cacciatore in the production of these new podcasts,” said Dr. John Geisler, WORD co-founder and Director of Gynecologic Oncology at University of Toledo.
Paul Cacciatore, Libby’s H*O*P*E* founder and podcast co-host said: “The WORD of HOPE™ ovarian cancer podcast series embodies the age old adage that ‘information is power’ — a potentially life-saving concept in the fight against the most lethal gynecologic cancer.” Mr. Cacciatore emphasized that the information featured in the podcast series is easy to understand and accessible from anywhere, including at home, on the job, or on the go through a smartphone or iPad. “WORD of HOPE™ not only raises much-needed ovarian cancer awareness in the minds of the general public, it educates survivors to proactively participate in their treatment through more meaningful dialogue with their doctors. Libby’s H*O*P*E* is proud to partner with WORD through this global form of social media.”
The first podcast installment will feature the following seven episodes (three already posted; four pending) which address ten significant 2010 scientific research and clinical treatment topics within the field of ovarian cancer:
- Avastin (Bevacizumab) Phase III Clinical Trials;
- PARP Inhibitors & BRCA Gene-Mutated Ovarian Cancer;
- NKTR-102, AMG 386, “Dose Dense” Paclitaxel (Taxol), and the Carboplatin/Pegylated Liposomal Doxorubicin (Doxil®) Drug Combination;
- ARID1A Gene Mutation In Endometriosis-Associated Ovarian Cancers;
- Reliance Upon CA-125 To Determine Ovarian Cancer Recurrence;
- Neoadjuvant Chemotherapy For Advanced Ovarian Cancer; and
- Diagnosis of Early Stage Ovarian Cancer: Risk of Ovarian Cancer Algorithm (ROCA) & Human Epididymis Protein 4 (HE4).
Viewers or listeners of WORD of HOPE™ Ovarian Cancer Podcast can contact Nathan Manahan, WORD Executive Director, via email to provide feedback and ideas for the podcast. To listen, watch or subscribe to the podcast series, visit http://www.wordofhopepodcast.com.
About the WORD of HOPE™ Podcast
Based in Indianapolis, Indiana (WORD) and Los Angeles, California (LH), WORD of HOPE™ serves viewers and listeners interested in up-to-date ovarian cancer information. Hosted by Nathan Manahan and Paul Cacciatore, WORD of HOPE™ ovarian cancer podcasts will be released several times a month and available for subscription through iTunes, RSS and YouTube.
About Women’s Oncology Research & Dialogue
Co-founded by gynecologic oncologists Drs. Kelly Manahan and John Geisler, WORD is an Indianapolis-based nonprofit organization dedicated to helping women conquer gynecologic cancers through catalyzing innovative scientific and clinical research, which results in empowering educational resources for women’s organizations and medical personnel regarding proper prevention, diagnosis and treatment.
About Libby’s H*O*P*E*™
Paul Cacciatore established Libby’s H*O*P*E*(*Helping *Ovarian Cancer Survivors *Persevere Through *Education)™ in March 2008 as an online resource to assist his 26-year-old cousin, Elizabeth “Libby” Remick, who was battling advanced-stage ovarian cancer. Although Libby ultimately lost her battle to the disease, Paul continues to assist ovarian cancer survivors worldwide, and their families and friends, through the website under the principle that “information is power” in the fight against ovarian cancer. Through Libby’s H*O*P*E*™, Paul has published approximately 250 weblog articles relating to ovarian cancer and cancer-related topics. Libby’s H*O*P*E*™ utilizes a variety of online media resources and social networks to disseminate critical information relating to ovarian cancer awareness, including the early warning signs and symptoms of the disease, important medical discoveries, relevant current clinical trials, and most importantly, stories of hope involving ovarian cancer survivors and their families. To learn more, visit https://healthinfoispower.wordpress.com